Skip to content
Harmonicare Pharmaceuticals logo — Committed to pioneering the future of innovative drug develo...

Harmonicare Pharmaceuticals

Committed to pioneering the future of innovative drug development

Series D Total: $300.00M Pharmaceutical

General Information

Company Name Harmonicare Pharmaceuticals
Industries Pharmaceutical
Funding Stage Series D
Social

BounceWatch is an independent company data service, not affiliated with Harmonicare Pharmaceuticals. To contact Harmonicare Pharmaceuticals, visit hemay.com.cn.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Harmonicare Pharmaceuticals compare?

A PDF of Harmonicare Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Harmonicare Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Harmonicare Pharmaceuticals

Harmonicare Pharmaceuticals is a pharmaceutical company committed to pioneering the future of innovative drug development. Founded with the purpose of researching and developing groundbreaking drugs, the company has recently attracted significant attention from investors with a CNY300.00M Series D investment at 08 February 2023. The notable investors participating in this investment round include Hongfu Assets, FaKong Industrial Investment, Taikun Capital, Anxin Guosheng Microchip Fund, and Zhenghan Investment. With a clear focus on the pharmaceutical industry, Harmonicare Pharmaceuticals showcases a promising trajectory in the realm of innovative drug development.

Business keywords: pharmaceutical company, drug development, innovative drugs, pharmaceutical industry, medical research, pharmaceutical innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series D CNY300.00M 5
Hongfu Assets, Taikun Capital +3
08 Feb 2023

Harmonicare Pharmaceuticals Alternatives & Competitors

View All Alternatives
Harmonicare Pharmaceuticals vs

Pioneering the future of medicine through groundbreaking drug development and advanced biopharmaceut...

Series A
Biotechnology, Pharmaceutical
Harmonicare Pharmaceuticals vs

Pioneering the future of tumor disease treatment through advanced pharmaceutical research and develo...

Series C
Biopharma, Pharmaceutical
Harmonicare Pharmaceuticals vs

Innovative drug delivery solutions enhancing the development and improvement of pharmaceuticals sinc...

Series B
Biotechnology, Health Care

FAQ About Harmonicare Pharmaceuticals

Committed to pioneering the future of innovative drug development
Harmonicare Pharmaceuticals operates in Pharmaceutical. Its work centres on pharmaceutical company, drug development, innovative drugs and pharmaceutical industry.
Harmonicare Pharmaceuticals has completed 1 funding round, raising a total of $300.00M. The latest funding stage is Series D.
Top alternatives and competitors to Harmonicare Pharmaceuticals include Cholesgen, Convalife Pharmaceuticals, Bostal Drug Delivery, Leadopharma, Venatorx Pharmaceuticals, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Harmonicare Pharmaceuticals and Cholesgen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Harmonicare Pharmaceuticals, https://bouncewatch.com/company/harmonicare-pharmaceuticals, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout